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Abstract
Background: Resistance to beta-Lactam antibiotics in Enterobacteriaceae is increasing worldwide; 
however, information about the different beta-Lactamase genes in diverse regions is scarce. We aimed to 
identify beta-lactamse genes in presumably ESBL positive isolates of Enterobacteriaceae.
Methods: A nonredundant collection of 757 strains of E. coli, Klebsiella pneumonia, Klebsiella oxytoca 
and Enterobacter cloacae resistant to third generation cephalosporins and ESBL positive by VITEK II 
analysis was analyzed by PCR for presence of beta-lactamase genes of the TEM, SHV, CTX-M and ampC 
families.
Results: Distribution of patient age was bimodal, with peaks at <1 year of age and at 60-80 years of age. 
The mean number of beta-Lactamase genes detected per strain was 2.01 (range 0-6), with E. cloacae 
tending to have more beta-lactamase genes than E. coli or Klebsiella spp. CTX-M genes, in particular from 
subgroup I, were most frequently detected, followed by SHV and TEM genes. Only 10% of the strains 
examined were positive for ampC genes. E. coli and K. pneumonia harbored ampC genes from several 
subgroups, while in E. cloacae and K. oxytoca, only EBC ampC genes were detected. Regarding overall 
beta-Lactamase diversity, E. coli and K. pneumonia have fewer, more dominating strains than K. oxytoca 
and E. cloacae, where the contribution of the most frequent strains to overall diversity is much lower. In 
47 strains from 23 patients, we found evidence of horizontal plasmid transfer occurring in vivo. Thus, 
among patients harboring >1 ESBL positive bacterial species, 71% may have been repeatedly colonized 
by different strains, while in 29%, plasmid transfer may have occurred after a single colonization event.
Conclusions: The molecular epidemiology of beta-Lactamase genes is complex even if analyzed in a 
single institution. CTX-M enzymes dominate, and co-occurrence of ampC enzymes is rare. Plasmid 
transfer between species of Enterobacteriaceae seems to occur in vivo in some patients.
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Case Report
The increase of antibiotic resistance in gram negative bacteria is 
of worldwide concern. Most prominently, resistance to oxyimino 
cephalosporins is mediated by Extended Spectrum beta-Lactamases 
(ESBL), which are often localized on mobile genetic elements like 
plasmids. Concomitantly with resistance against cephalosporins, 
these strains are often also resistant against non-beta-Lactam 
antimicrobials [1].
The molecular epidemiology of ESBLs is complex. Most the 
enzymes are from the Temoneira (TEM), sulfhydryl variable (SHV), 
and cefotaximinase (CTX-M) families, but several other ESBL families 
have also been described. Even within these families, heterogeneity is 
substantial, with 192 SHV genes, 231 TEM genes, and 166 CTX-M genes 
described to date (www.lahey.org/studies, accessed on Apr 10, 2015)
A proper understanding of ESBL epidemiology is important, 
since antibiotic resistant strains are of major concern especially, 
but not only, in hospitals. Recent studies showed that an increasing 
proportion of ESBL carriers, mostly carrying CTX-M enzymes, is 
community-associated [2]. Results from a check-up center in Paris, 
France, showed that the rate of community-associated ESBL carriage 
increased by a factor of 10 between 2006 and 2011 [3]. Recent data 
from Bavaria (Germany) demonstrate that 6.3% of healthy volunteers 
carry ESBL positive Enterobacteriaceae, most frequently CTX-M-15 
and CTX-M-1 genes [4]. More and more data suggest that this 
increase is associated with increasing ESBL rates in livestock, and 
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significant genetic similarities between ESBL isolates in chicken meat 
and humans could be demonstrated [5]. ESBLs have also recently 
been described in wildlife animals, with genes which are also found 
in humans [6].
Usually, ESBLs can easily be identified in the microbiology lab by 
phenotypic assays based on inhibition of cephalosporin hydrolysis by 
clavulanic acid [1]. However, co-occurrence of inhibitor resistant beta-
lactamases greatly reduces the accuracy of these assays. This occurs 
most often when plasmid-encoded ampC beta-lactamase genes are 
present additionally to the ESBL gene [7]. However, the precise rate of 
co-occurrence of ESBL and ampC genes is unknown. Moreover, to the 
best of our knowledge, there are no data derived from lager datasets 
comparing differences in ESBL genes occurring in Escherichia coli, 
Klebsiella species (spp.) and Enterobacter cloacae. Thus, we examined a 
large, non-redundant strain collection available at our institute for the 
occurrence and co-occurrence of the most frequently occurring ESBL 
and ampC genes.
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Materials and Methods
Between 2005 and 2009, strains of ESBL positive Enterobactariaceae 
were collected from routine microbiology samples submitted to the 
Institut für Medizinische Mikrobiologie, Immunologie und Hygiene 
of the Technische Universität München. Samples were cultured on 
blood, chocolate and MacConkey agar plates according to standard 
microbiology techniques, and clinically relevant strains were identified 
(Vitek II, Bio-Merieux; or Bruker Biotyper) and their antibiotic 
susceptibility determined (Vitek II AST-N117 cards), including an 
automated ESBL confirmatory test. Strains detected as ESBL positive 
were collected and stored for further analysis.
Before molecular analysis, the ESBL phenotype was first confirmed 
by E-Test (AB Biodisk) or double disk synergy test using cefotaxim, 
ceftazidim and cefpodoxim disks with and without clavulanic acid 
(BD Biosciences) for E. coli and Klebsiella spp., and cefepim disks with 
and without clavulanic acid (Mast Diagnostica) for E. cloacae isolates, 
according to Clinical and Laboratory Standards Institute (CLSI) 
standard procedures. Confirmed ESBL positive strains were submitted 
to PCR analysis using the following primers: broad range TEM as 
described in [8], broad range CTX-M as described in [9], CTX-M 
subgroups I and II as described in [10],  group III as described in [11], 
and groups IV and V as described in [9]. Primers for plasmidic ampC 
genes were from [12]. Broad range SHV primers were 5´- TTC GCC 
TGT GTA TTA TCT CC -´3 and 5´- TCC GCT CTG CTT TGT TAT 
TC -´3, developed by Y. Pfeifer, Robert Koch Institut in Wernigerode, 
Germany. PCR products were visualized by agarose gelelectrophoresis 
with ethidium bromide staining according to standard procedures. 
Data were collected and analyzed in Microsoft Excel.
Results
Sources of ESBL positive samples: Between Dec 2005 and Dec 2009, 
a total of 767 non-redundant strains of Enterobacteriaceae resistant to 
3rd generation cephalosporins and ESBL positive by Vitek II analysis
were collected at the Institut für Medizinische Mikrobiologie, 
Immunologie und Hygiene of the Technische Universität München. 
Two-hundred and forty-four (32%) strains were from intensive care 
units, 93 (12%) were from outpatient clinics. Most of the isolates 
were from urine (305 strains, 40%), 268 strains (35%) were from 
swab cultures, and 125 strains (16%) were from respiratory materials 
(tracheal secretions, bronchoalveolar lavage, or sputum). Twenty-
one (2.7%) and eleven (1.4%) strains were from blood cultures 
or intravascular devices, hence unambiguously indicate invasive 
infections. Almost half of the strains were detected in 60 to 80 year 
old patients (378 strains, 49%), but a second peak occurred in infants 
less than one year of age (45 strains, 5.8%) (Figure 1).
Microbiology of ESBL producers: Among the 767 strains analyzed 
were 448 E. coli, 245 K. pneumonia, 21 K. oxytoca and 53 E. cloacae 
strains. Genes for TEM- SHV-, CTX-M or ampC betalactamases 
could be detected by PCR in all but 9 strains. The mean number of 
detected beta-Lactamase genes per strain was 2.01. In E. cloacae, a 
mean of 3.25 beta-Lactamase genes could be detected per strain 
(range, 1 to 6), followed by K. pneumoniae (mean, 2.29, range 0-4), 
K. oxytoca (mean 1.86, range 1-4) and E. coli (mean 1.71, range 0-5) 
(Figure 2A).
Occurrence of TEM-, SHV-, CTX-M, and ampC beta-lactamases: 
The most frequent beta-Lactamase group was CTX-M, with a total 
of 645 strains positive. This was followed by SHV (418 strains) and 
TEM(294 strains) beta-lactamases (Figure 2B). Among E. coli, E. 
cloacae and K. oxytoca strains, the most frequent type was CTX-M 
with 87%, 83% and 100% of strains positive, respectively. By contrast, 
in K. pneumoniae strains, SHV genes were more frequent than CTX-M 
genes (95% vs. 78% of strains respectively). In E. cloacae, SHV and 
CTX-M genes occurred with similar frequency. Only 36% of E. coli 
strains carried a TEM gene.
A total of 80 strains were positive for ampC genes (Figure 2B), all 
but one E. coli strains with a single gene. EBC was the most frequent 
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Figure 1: Age dependent incidence of ESBL positive isolates of Enterobacteriaceae. X-axis: patient age at time of sample receipt in the 
clinical microbiology laboratory. Y-axis: number of ESBL positive isolates.
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one, being the sole ampC gene detected in E. cloacae and K. oxytoca 
strains. In E. cloacae, EBC occurred almost as often as SHV or 
CTX-M. Detection of ampC in E. coli and K. pneumonia was more 
diverse with DHA, EBC, FOX and CIT genes detected.
Figure 2C shows a detailed analysis of which genes occurred 
together in individual strains. In E. coli, most strains harbored only 
CTX-M gene(s), followed by co-occurrence of CTX-M with TEM 
and of CTX-M with SHV genes. By contrast, the combination of TEM 
with SHV and CTX-M genes was the most frequent genotype in K. 
pneumonia strains, followed by SHV and CTX-M genes occurring 
together. Still differently, in E. cloacae, the combination of SHV with 
CTX-M and ampC was most frequent. Importantly, only two strains 
harbored ampC genes without concurrent TEM-, SHV-, or CTX-M 
genes, indicating that false positive phenotypic ESBL tests by VITEK 
II analysis mediated by ampC genes are rare.
Occurrence of CTX-M subgroups: The most frequently detected 
CTX-M subgroup was CTX-M-I in E. coli, K. pneumonia and 
K. oxytoca (Figure 3A). However, in E. cloacae, CTX-M-II and 
CTX-M-IV genes were more frequent, these groups also were the 
second and third most frequent group in E. coli (Figure 3A). Thus, 
the repertoire of CTX-M genes was much broader in E.coli and E. 
cloacae than in Klebsiella spp. Only in 28 (4.3%) of all CTX-M positive 
strains, all CTX-M subgroup PCRs remained negative. Examining 
which subgroups frequently occur together in individual strains, the 
combination of CTX-M-II with CTX-M-IV was most frequent in all 
four species (Figure 3B). However, this combination was followed by 
CTX-M-I with CTX-M-II and CTX-M-IV in E. coli, by CTX-M-I 
with CTX-M-V in K. pneumonia, and by CTX-M-II with CTX-M-IV 
and CTX-M-V in E. cloacae.
Overall assessment of ESBL genotype diversity E. coli, K. 
pneumonia, K. oxytoca and E. cloacae: So far, our data indicate that 
there may be important differences in ESBL genotype between the four 
bacterial species examined. Figure 4 compares how many different 
strains contribute to overall genotype diversity in E. coli, Klebsiella 
spp. and E. cloacae. Interestingly, in E. coli and K. pneumonia, a much 
smaller proportion of all strains examined accounts for a given extend 
of genotypic variability than in K. oxytoca and E. cloacae. For example, 
in E. coli and K. pneumonia, less than 20% of the strains examined 
cover 80% of the detected genotypes.
By contrast, in K. oxytoca and E. cloacae, approx. 60% of the 
strains examined are needed to cover for 80% of the genotypes. Thus, 
regarding overall beta-Lactamase diversity, E. coli and K. pneumonia 
have fewer, more dominating strains than K.oxytoca and E. cloacae, 
where the contribution of the most frequent strains to overall number 
of genotypes is much lower.
Evidence for plasmid transfer between bacterial species in vivo in 
clinical settings: Our dataset contains 80 patients in which more than
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to a maximum of three different strains per patient (151 strains in 
total). We hypothesized that if inter-species plasmid transfer occurred 
in vivo in these patients, strains from different species should have 
the same beta-Lactamase genotype, except for beta-Lactamases which 
may be chromosomally encoded. We thus looked specifically for 
strains of different species detected in the same patient with identical 
beta-lactamase genotype, but accepting additional occurrence of 
potentially chromosomally encoded TEM in E. coli, SHV in Klebsiella 
spp. and EBC in E. cloacae. In fact, we could identify 23 patients with 
47 strains where plasmid transfer from one species to another may 
have occurred (Table 1). Thus, among patients harboring >1 ESBL 
positive bacterial species, 71% may have been repeatedly colonized 
by different strains, while in 29%, plasmid transfer may have occurred 
after a single colonization event.
Discussion
With a total of 767 nonredundant clinical strains analyzed, our 
study constitutes – to the best of our knowledge - the largest body of 
information about molecular epidemiology of broad spectrum beta-
lactamases to date. The vast majority of our strains (726 of 767) has 
been collected between 2007 and 2009 and comprises all different 
ESBL strains from our institution isolated in this timeframe. Like 
many other recent studies from Europe, we find a strong dominance 
of CTX-M enzymes in our dataset (84% of all strains tested were 
positive for CTX-M genes). Earlier, albeit much smaller, studies 
from Germany detected CTX-M enzymes in up to 98% of examined 
strains [13-15]. In 195 hospital-acquired strains of the U.S. SENTRY 
antimicrobial surveillance program, only 44% carried CTX-M genes 
[16]. However, another study detected CTX-M enzymes in 91% 
of community-acquired E. coli strains in the US [17]. Whether this 
constitutes a real difference, sampling bias, or changes in molecular
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Figure 3: (A) Distribution of CTX-M subgroups in E. coli, Klebsiella spp. and E. cloacae. (B) Co-occurrence of CTX-M subgroups in strains of E. coli, 
Klebsiella spp. and E. cloacae. y-axis gives the number of strains, while beta-lactamase genes or combinations thereof are indicated in the legend.
Figure 4: Cumulative frequency distribution of genotype diversity in E. coli, Klebsiella spp. 
and E. cloacae. x-axis: fraction of bacterial strains of the respective species in the study; y-axis: 
cumulative frequency of different beta-lactamase genotypes.
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TEM SHV CTX-M I II III IV V MOX DHA EBC ACC FOX CIT 
1 E. coli 0 1 1 0 1 0 1 0 0 0 0 0 0 0 
1 E. cloacae 0 1 1 0 1 0 1 0 0 0 1 0 0 0 
2 K. pneumoiae 0 1 1 1 0 0 0 0 0 0 0 0 0 0 
2 E. coli 1 1 1 1 0 0 0 0 0 0 0 0 0 0 
2 K. pneumoiae 1 1 1 1 0 0 0 0 0 0 0 0 0 0 
3 E. cloacae 0 1 1 0 1 0 1 0 0 0 1 0 0 0 
3 E. coli 1 1 1 0 1 0 1 0 0 0 0 0 0 0 
4 E. coli 1 1 1 0 1 0 1 0 0 0 0 0 0 0 
4 E. cloacae 0 1 1 0 1 0 1 0 0 0 1 0 0 0 
5 K. pneumoiae 1 1 1 1 0 0 0 0 0 0 0 0 0 0 
5 E. coli 0 1 1 1 0 0 0 0 0 0 0 0 0 0 
6 E. coli 0 1 1 0 1 0 1 0 0 0 0 0 0 0 
6 E. cloacae 0 1 1 0 1 0 1 0 0 0 1 0 0 0 
7 K. pneumoiae 0 1 1 1 0 0 0 0 0 0 0 0 0 0 
7 E. coli 1 0 1 1 0 0 0 0 0 0 0 0 0 0 
8 E. cloacae 0 1 1 0 1 0 1 0 0 0 1 0 0 0 
8 E. coli 0 1 1 0 1 0 1 0 0 0 1 0 0 0 
9 K. pneumoiae 0 1 1 1 0 0 0 0 0 0 0 0 0 0 
9 E. coli 0 0 1 1 0 0 0 0 0 0 0 0 0 0 
10 K. pneumoiae 0 1 1 1 0 0 0 0 0 0 0 0 0 0 
10 E. coli 0 0 1 1 0 0 0 0 0 0 0 0 0 0 
11 K. pneumoiae 0 1 1 1 0 0 0 0 0 0 0 0 0 0 
11 E. coli 1 0 1 1 0 0 0 0 0 0 0 0 0 0 
12 E. coli 1 1 1 0 1 0 1 0 0 0 0 0 0 0 
12 E. cloacae 0 1 1 0 1 0 1 0 0 0 1 0 0 0 
13 K. pneumoiae 0 0 1 1 0 0 0 0 0 0 0 0 0 0 
13 E. coli 0 0 1 1 0 0 0 0 0 0 0 0 0 0 
14 K. pneumoiae 1 1 1 1 0 0 0 0 0 0 0 0 0 0 
14 E. coli 1 0 1 1 0 0 0 0 0 0 0 0 0 0 
15 E. coli 1 1 1 0 1 0 1 0 0 0 0 0 0 0 
15 E. cloacae 0 1 1 0 1 0 1 0 0 0 1 0 0 0 
16 E. coli 0 0 1 1 0 0 0 0 0 0 0 0 0 0 
16 K. pneumoiae 0 1 1 1 0 0 0 0 0 0 0 0 0 0 
17 E. coli 1 1 1 0 1 0 1 0 0 0 0 0 0 0 
17 E. cloacae 0 1 1 0 1 0 1 0 0 0 1 0 0 0 
18 K. pneumoiae 0 1 1 1 0 0 0 0 0 0 0 0 0 0 
18 E. coli 1 0 1 1 0 0 0 0 0 0 0 0 0 0 
19 K. pneumoiae 1 0 1 1 0 0 0 0 0 0 0 0 0 0 
19 E. coli 1 0 1 1 0 0 0 0 0 0 0 0 0 0 
20 K. pneumoiae 1 1 0 x x x x x 0 0 0 0 0 0 
20 E. coli 1 1 0 x x x x x 0 0 0 0 0 0 
21 E. coli 0 1 0 x x x x x 0 0 0 0 0 0 
21 K. pneumoiae 0 1 0 x x x x x 0 0 0 0 0 0 
22 K. pneumoiae 1 1 1 1 0 0 0 0 0 0 0 0 0 0 
22 K. oxytoca 1 1 1 1 0 0 0 0 0 0 0 0 0 0 
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epidemiology over time remains to be determined: In suburban 
New York, the prevalence of CTX-M positive Klebsiella pneumonia 
isolates strongly increased in recent years, while the increase in 
CTX-M bearing E. coli was much less pronounced [18]. Similarly, an 
increase in CTX-M-bearing E. coli and Klebsiella spp. was described in 
Texas between 2000 and 2006 [11]. By 2012, CTX-M group I became 
the most prevalent group of ESBL throughout the United States, 
with 43% of 701 strains collected [19]. Recent data from Canadian 
hospitals show a similar dominance of CTX-M enzymes, particularly 
CTX-M15, as in Germany [20]. Thus, we conclude that our data are 
in accordance with the global spread of CTX-M enzymes currently 
described in several regions worldwide.
In the German studies, CTX-M15 was the most frequently isolated 
gene [13-15]; as this belongs to the CTX-M-I group, this is also in 
concordance with our data. It should be noted, however, that the 
predominance of certain CTX-M alleles shows substantial geographic 
variation: in Spain, the most common CTX-M allele is CTX-M14 
[21, 22]. In the US SENTRY dataset, CTX-M15 is the most frequently 
isolated CTX-M gene [16], as it is in Canada [16]. However, we would 
like to point out that the distribution of CTX-M alleles is different 
in different bacterial species: While the CTX-M-I group is the 
predominant group in E. coli and Klebsiella spp., this is not the case 
in E. cloacae, where subgroups CTX-MII and CTX-M-IV dominate. 
The reasons for this difference are currently unclear, since E. cloacae 
is only infrequently examined for ESBL production and molecular 
studies are rare. Qureshi et al reported that among 31 isolates from 
blood stream infections, 29 harbored an SHV-like ESBL, while only 
two strains carried a CTX-M enzyme [23]. While we also find a high 
proportion of our E. cloacae strains to carry SHV genes, most of them 
also have CTX-M genes. In Brazil, more than 50% of ESBL positive 
E. cloacae strains have been shown to carry CTX-M15, a result quite 
different from ours [24]. In China, most E. cloacae strains resistant 
to carbapenems have been shown to co-express TEM and CTX-M 
ESBLs, with a smaller proportion being positive for SHV enzymes 
[25]. Thus, in line with our data, the molecular epidemiology of ESBL 
producing E. cloacae may be more diverse worldwide than that of 
other Enterobacteriaceae.
We can confirm earlier data that most of the ESBL positive 
strains carry more than one beta-lactamase gene. In the SENTRY 
antimicrobial surveillance program, two to nine beta-lactamase 
genes were detected in individual strains [16]. In the US 2012 strain 
collection [19], 63% of the isolates carried more than one ESBL gene. 
Similarly, the Canadian CANWARD surveillance reported multiple 
beta-Lactamase production in 74% and 83% of ESBL-positive E. coli 
and Klebsiella spp., with a maximum of 4 genes detected [20].
The detection of chromosomally encoded EBC and SHV genes in E. 
cloacae and Klebsiella spp., respectively, indicates that the chosen PCR 
strategy works well. However, since we did not sequence individual 
amplicons, we were not able to differentiate non-ESBL from ESBL 
enzymes in strains positive for TEM- or SHV genes.
While the molecular epidemiology of ESBL genes has been 
extensively characterized, much less is known about co-occurrence 
with ampC genes. We found 80 strains positive for ampC genes, 
constituting approx. 10% of all strains analyzed. Remarkably similar 
numbers are reported from the SENTRY surveillance program (11%) 
[20], from an international strain collection acquired during the 
tigecycline phase 3 trials (8,5%) [8], and from the US 2012 strain 
collection [19]. However, another study from Singapore reported 
only one isolate among 54 tested co-expressing ESBL and ampC 
genes [26]. One limitation of our study is that our strain collection 
is biased against ampC producers: We only analyzed strains which 
were positive for ESBL confirmatory tests, and strains concurrently 
producing an ampC enzyme could be expected to be negative in the 
phenotypic ESBL confirmatory tests. However, only very few strains 
were cefotaxim resistant and negative in ESBL confirmatory tests 
(data not shown), so this should not significantly affect our results 
and precludes inclusion of these strains as a control group. It would, 
however, be possible to extend on our observations by analyzing with 
PCR all cefotaxim resistant isolates irrespective from the result of 
the ESBL confirmatory tests. While the possibility of horizontal gene 
transfer in vivo in patients seems obvious, only very limited data are 
available. Fernandez et al. [27] report a patient with recurrent urinary 
tract infections being colonized by E. coli and Proteus mirabilis 
harboring the same CTX-M-32 bearing plasmid, demonstrating that 
horizontal gene transfer may indeed be possible in vivo. Similarly, 
Göttig et al report the occurrence of horizontal gene transfer of an 
OXA-48 bearing plasmid from K. pneumonia to E. coli during a 
nosocomial outbreak in 1 of 6 patients [28]. More importantly, Doi et 
al. [29] try to quantify the extent of horizontal gene transfer and cross 
transmission, respectively, in long-term care facility patients. They 
found 6 occurrences of horizontal gene transfer events in 25 patients 
colonized with SHV-5 or SHV-12 bearing E. coli and K. pneumoniae 
strains (24%). This figure is quite similar to our analysis, where we 
found evidence of horizontal gene transfer in 29% of patients. We 
conclude that plasmid transfer in vivo in individual patients is not a 
rare, but rather a common, event.
According to our data, the molecular epidemiology of ESBL and 
ampC enzymes is complex. In our collection of 767 bacterial strains, 
we could detect 73 different genotypes. Castanheira et al reported 55 
different gene combinations among 157 isolates [16]. Jones reported 
50 genotypes from 272 isolates [8]. Thus, if a sufficiently large strain 
collection is analyzed, molecular epidemiology of ESBLs is as complex 
in a single institution as it is in national or even international strain 
collections.
Conclusion
Molecular epidemiology of beta-lactamase genes in enterobacterial 
strains positive in phenotypic ESBL assays is as complex in a single 
institution as it is on a national or international level. As in other parts 
of Europe, CTX-M enzymes dominate in our study. Co-occurrence 
of ESBL and plasmid-encoded ampC enzymes in species without
Citation: Bogner C, Miethke T, Wantia N, Gebhard F, Busch D, et al. (2016) Differences in ESBL Genes between E. coli, Klebsiella spp. and Enterobacter Cloacae 
Strains. Int J Clin Med Microbiol 1: 106. doi: http://dx.doi.org/10.15344/ijcmm/2016/106
       Page 6 of 7
23 K. pneumoiae 0 1 0 x x x x x 0 0 0 0 0 0 
23 E. coli 1 1 0 x x x x x 0 0 0 0 0 0 
20 K. pneumoiae 1 1 0 x x x x x 0 0 0 0 0 0 
Table 1: Evidence for horizontal plasmid transfer in individual patients. Shown are beta-lactamase genotypes of patients where identical 
plasmid encoded beta-lactamase genes occur in different bacterial species, indicating that horizontal gene transfer may have occurred.
0: PCR negative, 1: PCR positive, x: not tested
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chromosomally encoded ampC seems to be a rare event. By contrast, 
co-occurrence of different genes potentially encoding ESBL enzymes 
is frequent. Transfer of resistance plasmids between bacterial species 
seems to occur in a certain percentage of patients in vivo.
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